Emergent BioSolutions Statistics
Total Valuation
EBS has a market cap or net worth of $317.33 million. The enterprise value is $833.93 million.
Important Dates
The last earnings date was Wednesday, May 7, 2025, after market close.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
EBS has 54.34 million shares outstanding. The number of shares has increased by 3.58% in one year.
| Current Share Class | 54.34M |
| Shares Outstanding | 54.34M |
| Shares Change (YoY) | +3.58% |
| Shares Change (QoQ) | +5.72% |
| Owned by Insiders (%) | 2.64% |
| Owned by Institutions (%) | 66.31% |
| Float | 52.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 8.46 |
| PS Ratio | 0.32 |
| Forward PS | 0.32 |
| PB Ratio | 0.58 |
| P/TBV Ratio | 4.70 |
| P/FCF Ratio | 3.36 |
| P/OCF Ratio | 2.88 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 13.67, with an EV/FCF ratio of 8.83.
| EV / Earnings | n/a |
| EV / Sales | 0.86 |
| EV / EBITDA | 13.67 |
| EV / EBIT | n/a |
| EV / FCF | 8.83 |
Financial Position
The company has a current ratio of 6.32, with a Debt / Equity ratio of 1.20.
| Current Ratio | 6.32 |
| Quick Ratio | 3.15 |
| Debt / Equity | 1.20 |
| Debt / EBITDA | 10.91 |
| Debt / FCF | 7.05 |
| Interest Coverage | -0.69 |
Financial Efficiency
Return on equity (ROE) is -21.63% and return on invested capital (ROIC) is -1.88%.
| Return on Equity (ROE) | -21.63% |
| Return on Assets (ROA) | -1.63% |
| Return on Invested Capital (ROIC) | -1.88% |
| Return on Capital Employed (ROCE) | -3.20% |
| Revenue Per Employee | $1.07M |
| Profits Per Employee | -$146,222 |
| Employee Count | 900 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 1.89 |
Taxes
In the past 12 months, EBS has paid $69.30 million in taxes.
| Income Tax | 69.30M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +34.25% in the last 52 weeks. The beta is 2.09, so EBS's price volatility has been higher than the market average.
| Beta (5Y) | 2.09 |
| 52-Week Price Change | +34.25% |
| 50-Day Moving Average | 5.25 |
| 200-Day Moving Average | 8.18 |
| Relative Strength Index (RSI) | 57.12 |
| Average Volume (20 Days) | 1,217,482 |
Short Selling Information
The latest short interest is 9.02 million, so 16.61% of the outstanding shares have been sold short.
| Short Interest | 9.02M |
| Short Previous Month | 9.16M |
| Short % of Shares Out | 16.61% |
| Short % of Float | 17.06% |
| Short Ratio (days to cover) | 7.35 |
Income Statement
In the last 12 months, EBS had revenue of $965.40 million and -$131.60 million in losses. Loss per share was -$2.46.
| Revenue | 965.40M |
| Gross Profit | 353.30M |
| Operating Income | -42.10M |
| Pretax Income | -578.10M |
| Net Income | -131.60M |
| EBITDA | 61.00M |
| EBIT | -42.10M |
| Loss Per Share | -$2.46 |
Full Income StatementBalance Sheet
The company has $149.10 million in cash and $665.70 million in debt, giving a net cash position of -$516.60 million or -$9.51 per share.
| Cash & Cash Equivalents | 149.10M |
| Total Debt | 665.70M |
| Net Cash | -516.60M |
| Net Cash Per Share | -$9.51 |
| Equity (Book Value) | 552.70M |
| Book Value Per Share | 10.14 |
| Working Capital | 594.90M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $110.10 million and capital expenditures -$15.70 million, giving a free cash flow of $94.40 million.
| Operating Cash Flow | 110.10M |
| Capital Expenditures | -15.70M |
| Free Cash Flow | 94.40M |
| FCF Per Share | $1.74 |
Full Cash Flow StatementMargins
Gross margin is 36.60%, with operating and profit margins of -4.36% and -13.63%.
| Gross Margin | 36.60% |
| Operating Margin | -4.36% |
| Pretax Margin | -6.45% |
| Profit Margin | -13.63% |
| EBITDA Margin | 6.32% |
| EBIT Margin | -4.36% |
| FCF Margin | 9.78% |